Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Syed Naqvi

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCOM | Internal Med Hem-Onc
Address4301 W Markham
Little Rock AR 72205
ORCID ORCID Icon0009-0002-2946-512X Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Neupane K, Singstock M, Shah D, Dahal R, Mian H, Smith F, Chakraborty R, Al Hadidi S, Mainou M, Grajales-Cruz A, Naqvi SMH, Shain KH, Goodman A, Costa LJ, Qazilbash M, Mohyuddin GR. Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review. Br J Haematol. 2026 Mar; 208(3):829-836. PMID: 41482478.
      View in: PubMed
    2. Sabol HM, Anloague A, Kaur J, Bustamante-Gomez C, Khan S, Paxton BC, Nester MR, Hackney J, Diaz-delCastillo M, Mann D, Stambough JB, Barnes CL, Ambrogini E, Frontier A, Ebetino FH, Naqvi S, van Rhee F, Wardell CP, Drake MT, Nookaew I, Schinke C, Zangari M, Delgado-Calle J. Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition. Exp Hematol Oncol. 2025 Aug 22; 14(1):108. PMID: 40847323.
      View in: PubMed
    3. Naqvi S, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem. 2024 Aug; 5(4):789-792. PMID: 39157593.
      View in: PubMed
    4. Menon LP, Naqvi S, Maradana J, Edem D. Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review. Cureus. 2024 Jan; 16(1):e52260. PMID: 38352081.
      View in: PubMed
    5. Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer. 2021 07 01; 127(13):2251-2261. PMID: 33826754.
      View in: PubMed
    Naqvi's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description